A new period of consolidation for diagnostics
This article was originally published in Clinica
Consolidation in the diagnostics sector is gathering pace. The number of deals has been steadily increasing over the last three years, from 31 in 2009 to 45 in 2011. In just the first four months of 2012, 15 deals were announced. Average deal value shot up from around $180m in 2009 to almost $700m so far in 2012, according to figures in a yet-to-be released study from the publishers of Clinica.
You may also be interested in...
An algorithm has been shown to be as effective as radiologists in spotting breast cancer from mammograms, backing previous predictions that machine learning will find increasing use as a "second reader" in screening programs.
Artificial intelligence (AI) and machine learning took center stage at this year’s Radiological Society of North America meeting in Chicago, and the pervasiveness of AI tech in new product launches was further emphasized at the RSNA’s expanded AI Showcase exhibit.
The French start-up claims first-in-man success for heart valve “softening” treatment and plans further trials for an EU launch.